| STOKE THERAPEUTICS |
| USA |
| Gesundheit |
| US86150R1077 / A2PLTL |
| 0GT (Frankfurt) / STOK (NASDAQ) |
| FRA:0GT, ETR:0GT, 0GT:GR, NASDAQ:STOK |
| - |
| https://www.stoketherapeu.. |
|
Stoke Therapeutics Inc. is a biotechnology company focused on developing RNA-based treatments for genetic diseases. Its primary aim is to address disorders caused by a lack of protein expression due t..
>Volltext.. |
| 1584.79 Mio. EUR |
| 1347.93 Mio. EUR |
| 159.29 Mio. EUR |
| -14.18 Mio. EUR |
| -5.95 Mio. EUR |
| -0.08 EUR |
| 3.58 Mio. EUR |
| 73.17 Mio. EUR |
| 39.37 Mio. EUR |
| 4.93 |
| 344.67% |
| 93.18% |
| - |
| - |
| - |
| STOKE THERAPEUTICS, STOKE THERAPEUTIC |
| 20.03.26 |
|
||||
|